Strata Skin Sciences Operating Margin 2010-2025 | SSKN
Current and historical operating margin for Strata Skin Sciences (SSKN) over the last 10 years. The current operating profit margin for Strata Skin Sciences as of March 31, 2025 is -27.22%.
| Strata Skin Sciences Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-03-31 | $0.03B | $-0.01B | -23.53% |
| 2024-12-31 | $0.03B | $-0.01B | -26.47% |
| 2024-09-30 | $0.03B | $-0.01B | -24.24% |
| 2024-06-30 | $0.03B | $-0.01B | -21.21% |
| 2024-03-31 | $0.03B | $-0.01B | -27.27% |
| 2023-12-31 | $0.03B | $-0.01B | -26.47% |
| 2023-09-30 | $0.04B | $-0.01B | -16.67% |
| 2023-06-30 | $0.04B | $-0.01B | -16.67% |
| 2023-03-31 | $0.04B | $-0.01B | -16.22% |
| 2022-12-31 | $0.04B | $-0.01B | -13.89% |
| 2022-09-30 | $0.03B | $-0.01B | -17.65% |
| 2022-06-30 | $0.03B | $-0.01B | -15.15% |
| 2022-03-31 | $0.03B | $0.00B | -12.90% |
| 2021-12-31 | $0.03B | $0.00B | -13.33% |
| 2021-09-30 | $0.03B | $0.00B | -10.71% |
| 2021-06-30 | $0.03B | $0.00B | -15.38% |
| 2021-03-31 | $0.02B | $-0.01B | -21.74% |
| 2020-12-31 | $0.02B | $0.00B | -16.67% |
| 2020-09-30 | $0.03B | $0.00B | -15.38% |
| 2020-06-30 | $0.03B | $0.00B | -14.81% |
| 2020-03-31 | $0.03B | $0.00B | -9.68% |
| 2019-12-31 | $0.03B | $0.00B | -9.68% |
| 2019-09-30 | $0.03B | $0.00B | -10.00% |
| 2019-06-30 | $0.03B | $0.00B | -6.45% |
| 2019-03-31 | $0.03B | $0.00B | -6.67% |
| 2018-12-31 | $0.03B | $0.00B | -10.00% |
| 2018-09-30 | $0.03B | $0.00B | -12.90% |
| 2018-06-30 | $0.03B | $-0.01B | -16.67% |
| 2018-03-31 | $0.03B | $0.00B | -12.90% |
| 2017-12-31 | $0.03B | $0.00B | -9.68% |
| 2017-09-30 | $0.03B | $0.00B | -6.67% |
| 2017-06-30 | $0.03B | $0.00B | -3.23% |
| 2017-03-31 | $0.03B | $0.00B | -6.45% |
| 2016-12-31 | $0.03B | $0.00B | -9.38% |
| 2016-09-30 | $0.03B | $-0.01B | -15.15% |
| 2016-06-30 | $0.03B | $-0.01B | -21.21% |
| 2016-03-31 | $0.03B | $-0.02B | -57.69% |
| 2015-12-31 | $0.02B | $-0.02B | -94.44% |
| 2015-09-30 | $0.01B | $-0.02B | -211.11% |
| 2015-06-30 | $0.00B | $-0.02B | -2100.00% |
| 2015-03-31 | $0.00B | $-0.02B | 0.00% |
| 2014-12-31 | $0.00B | $-0.02B | 0.00% |
| 2014-09-30 | $0.00B | $-0.02B | 0.00% |
| 2014-06-30 | $0.00B | $-0.02B | 0.00% |
| 2014-03-31 | $0.00B | $-0.02B | 0.00% |
| 2013-12-31 | $0.00B | $-0.02B | 0.00% |
| 2013-09-30 | $0.00B | $-0.03B | 0.00% |
| 2013-06-30 | $0.00B | $-0.02B | 0.00% |
| 2013-03-31 | $0.00B | $-0.02B | 0.00% |
| 2012-12-31 | $0.00B | $-0.02B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.010B | $0.034B |
| Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.084B | 57.36 |
| Doximity (DOCS) | United States | $11.307B | 52.35 |
| Hims & Hers Health (HIMS) | United States | $10.719B | 111.37 |
| Tempus AI (TEM) | United States | $9.847B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.340B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.842B | 60.03 |
| Hinge Health (HNGE) | United States | $3.717B | 0.00 |
| Privia Health (PRVA) | United States | $2.496B | 170.58 |
| Enovis (ENOV) | United States | $1.944B | 10.84 |
| Phreesia (PHR) | United States | $1.590B | 0.00 |
| 10x Genomics (TXG) | United States | $1.576B | 0.00 |
| Schrodinger (SDGR) | United States | $1.542B | 0.00 |
| Azenta (AZTA) | United States | $1.532B | 71.21 |
| Clover Health Investments (CLOV) | United States | $1.486B | 0.00 |
| Omnicell (OMCL) | United States | $1.344B | 23.71 |
| Evolent Health (EVH) | United States | $1.313B | 111.80 |
| Claritev (CTEV) | United States | $0.761B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.587B | 0.00 |
| Veradigm (MDRX) | United States | $0.547B | 0.00 |
| Standard BioTools (LAB) | United States | $0.501B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.448B | 0.00 |
| Talkspace (TALK) | United States | $0.442B | 132.00 |
| Outset Medical (OM) | United States | $0.344B | 0.00 |
| TruBridge (TBRG) | United States | $0.331B | 735.33 |
| Health Catalyst (HCAT) | United States | $0.271B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.258B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.233B | 0.00 |
| CapsoVision (CV) | United States | $0.212B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.161B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.150B | 0.00 |
| American Well (AMWL) | United States | $0.131B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.123B | 0.00 |
| Pulmonx (LUNG) | United States | $0.117B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.103B | 0.00 |
| CareCloud (CCLD) | United States | $0.101B | 3.84 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.082B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.068B | 0.00 |
| 111 (YI) | China | $0.065B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.045B | 0.00 |
| HeartBeam (BEAT) | United States | $0.042B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| Precipio (PRPO) | United States | $0.024B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |